Koltan

Kolltan Pharmaceuticals discovers and develops novel antibody-based drugs for the treatment of cancer and other diseases.

Kolltan Pharmaceuticals was acquired by Celldex Therapeutics in late 2016.

 

VISIT WEBSITE Back to Portfolio